Recent years have witnessed significant advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as promising https://sashaltlr270690.eedblog.com/39218030/exploring-the-future-of-type-2-diabetes-treatment-retatrutide-and-trizepatide